We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Image: Prof. Dr. David Ellinghaus and Frauke Degenhardt, both first authors of the study (Photo courtesy of UKSH Kiel)

Genes and Blood Type Determine Risk of COVID-19 Severity

A team of researchers have found gene variants for severe course of COVID-19, indicating that blood group might have an influence on the severity of the disease’s symptoms. More...
24 Jun 2020
Image: Predictive analytics platform CLEW (Photo courtesy of CLEW)

AI-Based Predictive Analytics Platform Receives FDA Emergency Use Authorization in Support of COVID-19 Patients

CLEW-ICU, a new ICU solution, has become the only device to receive FDA Emergency Use Authorization (EUA) for providing early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19. More...
24 Jun 2020
Image: Flowbot ONE (Photo courtesy of Flow Robotics)

New Pipetting Robot Automates COVID-19 Testing Processes to Reduce Repetitive Work and Accidents

A new pipetting robot is automating COVID-19 testing processes in European hospitals, thereby significantly reducing the time taken by laboratories to generate results. More...
24 Jun 2020
Image: Randox Cytokine Biochip (Photo courtesy of Randox Laboratories)

Randox Unveils Cytokine Testing for COVID-19 Risk Stratification and Treatment Monitoring

Global diagnostics company Randox Laboratories (Crumlin, UK) has unveiled cytokine testing for COVID-19 risk stratification and treatment monitoring. More...
24 Jun 2020
Image: Professor Sanjeev Krishna, Professor of Molecular Parasitology and Medicine, Infection and Immunity Research Institute St George`s (Photo courtesy of St George’s, University of London)

Coronavirus Immunity in COVID-19 Patients May Not Last More Than Two Months, Finds New Study

Initial results from an antibody testing study have revealed that COVID-19 antibodies remain stable in the blood of the majority of infected individuals almost two months after diagnosis and possibly longer. More...
23 Jun 2020
Illustration

Gilead Receives US FDA Approval to Begin Clinical Trials of Inhaled Version of Remdesivir

Gilead Sciences, Inc. (Foster City, CA, USA) has received the go-ahead from the US Food and Drug Administration (FDA Silver Spring, MD, USA) to begin trials of an inhaled version of its antiviral drug remdesivir in patients with COVID-19. More...
23 Jun 2020
Image: UV-C Light Kills SARS-CoV-2 Virus Within Seconds of Exposure in Lab Study (Photo courtesy of Signify)

UV-C Light Kills SARS-CoV-2 Virus Within Seconds of Exposure in Lab Study

A UV-C lighting technology developed by Signify (Eindhoven, The Netherlands) has proven to be effective in inactivating the SARS-CoV-2 virus in research studies. More...
23 Jun 2020
Visit expo >
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Phototherapy Eye Protector
EyeMax2
New
Transcatheter Heart Valve
SAPIEN 3 Ultra

In Other News

Copyright © 2000 - 2024 Globetech Media.
All rights reserved.